LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel: Panic attacks associated with citalopram.

    Brauer, Heidi R / Nowicki, Paul W / Catalano, Glenn / Catalano, Maria C

    Southern medical journal

    2002  Band 95, Heft 9, Seite(n) 1088–1089

    Abstract: Citalopram is the newest selective serotonin reuptake inhibitor (SSRI) available in the United States. It is currently approved by the Food and Drug Administration for the treatment of major depression. However, a number of studies have found it to be ... ...

    Abstract Citalopram is the newest selective serotonin reuptake inhibitor (SSRI) available in the United States. It is currently approved by the Food and Drug Administration for the treatment of major depression. However, a number of studies have found it to be effective in the treatment of panic disorder as well. While there have been no previous case reports of citalopram inducing panic attacks in patients, this phenomenon has been reported with other members of the SSRI class of antidepressants. We present the case of a 61-year-old woman who had frank panic attacks after her citalopram dose was increased. She had had no history of anxiety symptoms. Anxiety abated completely upon discontinuance of citalopram therapy.
    Mesh-Begriff(e) Citalopram/adverse effects ; Female ; Humans ; Middle Aged ; Panic Disorder/chemically induced ; Serotonin Uptake Inhibitors/adverse effects
    Chemische Substanzen Serotonin Uptake Inhibitors ; Citalopram (0DHU5B8D6V)
    Sprache Englisch
    Erscheinungsdatum 2002-09
    Erscheinungsland United States
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 185329-6
    ISSN 1541-8243 ; 0038-4348
    ISSN (online) 1541-8243
    ISSN 0038-4348
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Topiramate Overdose: A Case Report and Literature Review.

    Smith, Amanda G. / Brauer, Heidi R. / Catalano, Glenn / Catalano, Maria C.

    Epilepsy & behavior : E&B

    2001  Band 2, Heft 6, Seite(n) 603–607

    Abstract: Topiramate is a medication introduced in the United States in 1997 for the treatment of epilepsy. Studies are currently underway to determine its effectiveness in the treatment of multiple conditions including bipolar disorder. It is generally well ... ...

    Abstract Topiramate is a medication introduced in the United States in 1997 for the treatment of epilepsy. Studies are currently underway to determine its effectiveness in the treatment of multiple conditions including bipolar disorder. It is generally well tolerated at doses commonly used in the clinical setting, however, there is little information regarding its safety in overdose. We report the case of a 24-year-old woman who ingested 4000 mg of topiramate in a suicide attempt. She was asymptomatic following the overdose and did not develop any adverse sequelae. In this article we will discuss the commonly seen side effects of topiramate use and examine the available data concerning topiramate overdose. We will review recommendations for the management of such an overdose.
    Sprache Englisch
    Erscheinungsdatum 2001-12
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2010587-3
    ISSN 1525-5069 ; 1525-5050
    ISSN (online) 1525-5069
    ISSN 1525-5050
    DOI 10.1006/ebeh.2001.0299
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang